|
1
|
Allamand V and Guicheney P:
Merosin-deficient congenital muscular dystrophy, autosomal
recessive (MDC1A, MIM#156225, LAMA2 gene coding for alpha2 chain of
laminin). Eur J Hum Genet. 10:91–94. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sparks S, Quijano-Roy S, Harper A, et al:
Congenital Muscular Dystrophy Overview, 2012.
GeneReviews® [Internet]. Pagon RA, Bird TD, Dolan CR, et
al: University of Washington; Seattle, WA: 1993–2014
|
|
3
|
Kobayashi O, Hayashi Y, Arahata K, Ozawa E
and Nonaka I: Congenital muscular dystrophy: Clinical and
pathologic study of 50 patients with the classical (Occidental)
merosin-positive form. Neurology. 46:815–818. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Louhichi N, Triki C, Quijano-Roy S,
Richard P, Makri S, Méziou M, Estournet B, Mrad S, Romero NB, Ayadi
H, et al: New FKRP mutations causing congenital muscular dystrophy
associated with mental retardation and central nervous system
abnormalities. Identification of a founder mutation in Tunisian
families. Neurogenetics. 5:27–34. 2004. View Article : Google Scholar
|
|
5
|
Voit T, Cirak S, Abraham S, Karakesisoglou
I, Parano E, Pavone P, Falsaperla R, Amthor H, Schroeder J, Mutoni
F, et al: Congenital muscular dystrophy with adducted thumbs,
mental retardation, cerebellar hypoplasia and cataracts is caused
by mutation of Enaptin (Nesprin-1): The third nuclear envelopathy
with muscular dystrophy. In: Proceedings of the 12th International
Congress of the World-Muscle-Society Italy Neuromuscular Disorders;
Pergamon-Elsevier Science Ltd; Oxford, UK: pp. 833–834. 2007
|
|
6
|
Messina S, Tortorella G, Concolino D,
Spanò M, D’Amico A, Bruno C, Santorelli FM, Mercuri E and Bertini
E: Congenital muscular dystrophy with defective alpha-dystroglycan,
cerebellar hypoplasia, and epilepsy. Neurology. 73:1599–601. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Quijano-Roy S, Sparks S and Rutkowski A:
LAMA 2-Related Muscular Dystrophy, 2012. GeneReviews®
[Internet]. Pagon RA, Bird TD, Dolan CR, et al: University of
Washington; Seattle, WA: 1993–2014
|
|
8
|
Mostacciuolo ML, Miorin M, Martinello F,
Angelini C, Perini P and Trevisan CP: Genetic epidemiology of
congenital muscular dystrophy in a sample from north east Italy.
Hum Genet. 97:277–279. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Darin N and Tulinius M: Neuromuscular
disorders in childhood: a descriptive epidemiological study from
western Sweden. Neuromuscul Disord. 10:1–9. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Suzuki N, Yokoyama F and Nomizu M:
Functional sites in the laminin alpha chains. Connect Tissue Res.
46:142–152. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hall TE, Bryson-Richardson RJ, Berger S,
Jacoby AS, Cole NJ, Hollway GE, Berger J and Currie PD: The
zebrafish candyfloss mutant implicates extracellular matrix
adhesion failure in laminin alpha2-deficient congenital muscular
dystrophy. Proc Natl Acad Sci USA. 104:7092–7097. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang Y, Muzny DM, Reid JG, et al: Clinical
whole-exome sequencing for the diagnosis of mendelian disorders. N
Engl J Med. 369:1502–1511. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Biesecker LG, Burke W, Kohane I, et al:
Next-generation sequencing in the clinic: are we ready? Nat Rev
Genet. 13:818–824. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Iqbal Z, Neveling K, Razzaq A, Shahzad M,
Zahoor MY, Qasim M, Gilissen C, Wieskamp N, Kwint MP, Gijsen S, et
al: Targeted next generation sequencing reveals a novel intragenic
deletion of the TPO gene in a family with intellectual disability.
Arch Med Res. 43:312–316. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wei X, Jin F, Ye Y, Xu C, Qu N, Ju X and
Yi X: A novel mutation of IDS gene in a Chinese patient with
mucopolysaccharidosis II by next-generation sequencing. Clin Chim
Acta. 412:2340–2342. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wei X, Sun Y, Xie J, Shi Q, Qu N, Yang G,
Cai J, Yang Y, Liang Y, Wang W and Yi X: Next-generation sequencing
identifies a novel compound heterozygous mutation in MYO7A in a
Chinese patient with Usher Syndrome 1B. Clin Chim Acta.
413:1866–1871. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jones MA, Bhide S, Chin E, Ng BG,
Rhodenizer D, Zhang VW, Sun JJ, Tanner A, Freeze HH and Hegde MR:
Targeted polymerase chain reaction-based enrichment and next
generation sequencing for diagnostic testing of congenital
disorders of glycosylation. Genet Med. 13:921–932. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mendell JR and Florence J: Manual muscle
testing. Muscle Nerve. 13(Suppl): S16–S20. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ames LB, Gillespie BS, Haines J and Ilg
FL: The Gesell Institute’s child from one to six: Evaluating the
behavior of the preschool child. Harper & Row; New York:
1979
|
|
20
|
Illumina Protocol for Whole Genome
Sequencing using SBS Technology. BioTechniques Protocol Guide.
Biotechniques; New York, NY: 2006
|
|
21
|
Chilamakuri CS, Lorenz S, Madoui MA, Vodák
D, Sun J, Hovig E, Myklebost O and Meza-Zepeda LA: Performance
comparison of four exome capture systems for deep sequencing. BMC
Genomics. 15:4492014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Guo G, Sun X, Chen C, Wu S, et al:
Whole-genome and whole-exome sequencing of bladder cancer
identifies frequent alterations in genes involved in sister
chromatid cohesion and segregation. Nat Genet. 45:1459–1463. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wei X, Ju X, Yi X, Zhu Q, Qu N, et al:
Identification of sequence variants in genetic disease-causing
genes using targeted next-generation sequencing. PLoS One.
6:e295002011. View Article : Google Scholar
|
|
24
|
Li H and Durbin R: Fast and accurate
long-read alignment with Burrows-Wheeler transform. Bioinformatics.
26:589–595. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li R, Li Y, Fang X, Yang H and Wang J,
Kristiansen K and Wang J: SNP detection for massively parallel
whole-genome resequencing. Genome Res. 19:1124–1132. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li H, Handsaker B, Wysoker A, Fennell T,
Ruan J, Homer N, Marth G, Abecasis G and Durbin R: 1000 Genome
Project Data Processing Subgroup: The Sequence alignment/map (SAM)
format and SAMtools. Bioinformatics. 25:2078–2079. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Goossens D, Moens LN, Nelis E, Lenaerts
AS, Glassee W, Kalbe A, Frey B, Kopal G, De Jonghe P, De Rijk P and
Del-Favero J: Simultaneous mutation and copy number variation (CNV)
detection by multiplex PCR-based GS-FLX sequencing. Hum Mutat.
30:472–476. 2009. View Article : Google Scholar
|
|
28
|
Kumps C, Van Roy N, Heyrman L, Goossens D,
Del-Favero J, Noguera R, Vandesompele J, Speleman F and De Preter
K: Multiplex Amplicon Quantification (MAQ), a fast and efficient
method for the simultaneous detection of copy number alterations in
neuroblastoma. BMC Genomics. 11:2982010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Guicheney P, Vignier N, Zhang X, He Y,
Cruaud C, Frey V, Helbling-Leclerc A, Richard P, Estournet B,
Merlini L, et al: PCR based mutation screening of the laminin
alpha2 chain gene (LAMA2): application to prenatal diagnosis and
search for founder effects in congenital muscular dystrophy. J Med
Genet. 35:211–217. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hellemans J, Mortier G, De Paepe A,
Speleman F and Vandesompele J: qBase relative quantification
framework and software for management and automated analysis of
real-time quantitative PCR data. Genome Biol. 8:R192007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Katsanis SH and Katsanis N: Molecular
genetic testing and the future of clinical genomics. Nat Rev Genet.
14:415–426. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Vasli N and Laporte J: Impacts of
massively parallel sequencing for genetic diagnosis of
neuromuscular disorders. Acta Neuropathol. 125:173–185. 2013.
View Article : Google Scholar
|
|
33
|
Bell CJ, Dinwiddie DL, Miller NA, et al:
Carrier testing for severe childhood recessive diseases by
next-generation sequencing. Sci Transl Med. 3:65ra42011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Umbarger MA, Kennedy CJ, Kennedy CJ,
Saunders P, et al: Next-generation carrier screening. Genet Med.
16:132–140. 2014. View Article : Google Scholar :
|
|
35
|
Oliveira J, Santos R, Soares-Silva I,
Jorge P, et al: LAMA2 gene analysis in a cohort of 26 congenital
muscular dystrophy patients. Clin Genet. 74:502–512. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Di Blasi C, Piga D, Brioschi P, et al:
LAMA2 gene analysis in congenital muscular dystrophy: new
mutations, prenatal diagnosis, and founder effect. Arch Neurol.
62:1582–1586. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yamamoto LU, Gollop TR, Naccache NF, et
al: Protein and DNA analysis for the prenatal diagnosis of
alpha2-laminin-deficient congenital muscular dystrophy. Diagn Mol
Pathol. 13:167–171. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Engvall E and Wewer UM: Domains of
laminin. J Cell Biochem. 61:493–501. 1996. View Article : Google Scholar : PubMed/NCBI
|
